How Preclinical Cardiovascular Anesthetized Data Translates into the Clinic

Posted by Michael Gralinski, Chief Executive Officer at CorDynamics on July 17th, 2012

Translating preclinical cardiovascular data into clinical success is the name of the R&D game.

Anesthetized models are some of the most sensitive assays researchers can use to investigate the cardiovascular effects of their lead candidates and back-up compounds.

The thoroughly validated research and a wealth of scientific publications demonstrate that anesthetized studies in several subject species (canine, rat, guinea pig, rabbit, NHP) are highly predictive and similar to those observed in humans.

This is imperative as the FDA and the Committee for Proprietary and Medicinal Products (CPMP) firmly advocate that preclinical and clinical tests for adverse cardiovascular potential be performed for all new pharmaceutical compounds, regardless of the intended therapeutic application.

Anesthetized studies can be designed with advanced hemodynamics and electrophysiological testing to assess a variety of cardiovascular effects.

• Advanced hemodynamics
• Heart rate
• Systemic blood pressures
• Pulmonary artery pressure
• Left ventricular pressures and derivatives
• Cardiac output
• Blood flow
• PK/PD relationships
• Electrocardiograms

Armed with this critical data, developers can translate their preclinical results into strategies for improved clinical performance.

Leave a Reply